Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.35591675
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.26 -0.02 (-1.56%)

91.75% Fall from 52W High

1.2M

XNAS Volume

High vol.+loss this week

XNAS 09 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

15.7 / 100

Technically Neutral

38.6 / 100

1Yr Price target upside is 3089%

11 analysts

Pliant Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

91.75% Fall from 52W High

High vol.+loss this week

SWOT Analysis

Pliant Therapeutics Inc Live Price Chart